Income Statement

v3.8.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2017
Oct. 31, 2016
Operating costs and expenses    
Research and development $ 7,107
Research and development - intellectual property acquired 104,693
General and administrative 18,812 4,099
Operating costs and expenses total 130,612 4,099
Operating loss (130,612) (4,099)
Other income    
Interest income 23 18
Change in fair value of derivatives 109 248
Net loss from continuing operations (130,480) (3,833)
Loss from discontinued operations (449) (807)
Gain on sale of discontinued operations 100
Loss from discontinued operations, net (349) (807)
Net loss (130,829) (4,640)
Special cash dividend attributable to preferred stockholders (6,002)
Deemed dividend - accretion of discount on Series F preferred stock (369)
Cumulative dividends on Series F preferred stock (124)
Net loss attributable to common stockholders $ (131,322) $ (10,642)
Net loss per share, basic and diluted:    
Loss from continuing operations $ (26.50) $ (1.83)
Loss from discontinued operations (0.07) (0.38)
Net loss (26.57) (2.21)
Special cash dividend attributable to preferred stockholders (2.87)
Deemed dividend - accretion of discount on Series F preferred stock (0.07)
Cumulative dividends on Series F preferred stock (0.03)
Net loss attributable to common stockholders $ (26.67) $ (5.08)
Weighted average shares outstanding, basic and diluted: 4,923,327 2,096,022

Source